PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $928,000 | -49.9% | 318,608 | -50.0% | 0.00% | -25.0% |
| Q2 2020 | $1,854,000 | -8.5% | 637,216 | -11.3% | 0.00% | -20.0% |
| Q1 2020 | $2,026,000 | -3.4% | 718,216 | +11.1% | 0.01% | +25.0% |
| Q4 2019 | $2,098,000 | +50.3% | 646,400 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $1,396,000 | +203.5% | 646,400 | +341.5% | 0.00% | +200.0% |
| Q2 2019 | $460,000 | +666.7% | 146,400 | +607.2% | 0.00% | – |
| Q4 2018 | $60,000 | +11.1% | 20,700 | 0.0% | 0.00% | – |
| Q3 2018 | $54,000 | -84.7% | 20,700 | -86.3% | 0.00% | -100.0% |
| Q2 2018 | $353,000 | -58.1% | 150,900 | -47.3% | 0.00% | -66.7% |
| Q1 2018 | $842,000 | -9.3% | 286,500 | -15.4% | 0.00% | -25.0% |
| Q4 2017 | $928,000 | +1225.7% | 338,800 | +1536.7% | 0.00% | – |
| Q3 2017 | $70,000 | -74.8% | 20,700 | -84.2% | 0.00% | -100.0% |
| Q4 2016 | $278,000 | -71.3% | 131,000 | -54.6% | 0.00% | -75.0% |
| Q3 2016 | $967,000 | +0.5% | 288,800 | -5.7% | 0.00% | 0.0% |
| Q2 2016 | $962,000 | -20.8% | 306,400 | -16.0% | 0.00% | -20.0% |
| Q1 2016 | $1,214,000 | -38.2% | 364,700 | -34.3% | 0.01% | -44.4% |
| Q4 2015 | $1,964,000 | -31.5% | 554,700 | -2.7% | 0.01% | -25.0% |
| Q3 2015 | $2,869,000 | -18.0% | 570,300 | +4.9% | 0.01% | -14.3% |
| Q2 2015 | $3,497,000 | -12.5% | 543,900 | -4.3% | 0.01% | -12.5% |
| Q1 2015 | $3,997,000 | -1.2% | 568,200 | +8.3% | 0.02% | 0.0% |
| Q4 2014 | $4,045,000 | -40.0% | 524,700 | -41.9% | 0.02% | -44.8% |
| Q3 2014 | $6,745,000 | +8.8% | 903,000 | +41.0% | 0.03% | +11.5% |
| Q2 2014 | $6,200,000 | +18.8% | 640,500 | +2.0% | 0.03% | +13.0% |
| Q1 2014 | $5,219,000 | +75.3% | 628,000 | +78.1% | 0.02% | +76.9% |
| Q4 2013 | $2,977,000 | +37.4% | 352,700 | +29.8% | 0.01% | +18.2% |
| Q3 2013 | $2,166,000 | +13.5% | 271,800 | +9.9% | 0.01% | +10.0% |
| Q2 2013 | $1,909,000 | – | 247,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |